Learn everything you need to know about Ethinyl Estradiol and Levonorgestrel-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side ...
Review the side-effects of Ethinyl Estradiol and Levonorgestrel as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the ...
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial ...
QUARTETTE (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Teva announced the launch of Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the prevention of ...
NORTH WALES, Pa., Sept. 24, 2013 /PRNewswire/ -- Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette™ ...
Twirla (levonorgestrel and ethinyl estradiol) transdermal system is now available as a method of contraception for use in women of reproductive potential with a BMI Twirla® (levonorgestrel and ethinyl ...
PRINCETON, N.J. and CHARLESTON, S.C., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced a new alliance with Afaxys Pharma, LLC to ...
TWIRLA is indicated as a method of contraception for use in women of reproductive potential with a BMI 30 kg/m2 for whom a combined hormonal contraceptive is appropriate. Limitations of Use Consider ...
Shares of Glenmark Pharma climbed 1.7 percent intraday Monday on receiving final approval from the USFDA for its extended cycle oral contraceptives. Advisory Alert: It has come to our attention that ...
Glenmark Pharmaceuticals USA has been granted tentative approval by the USFDA for Norethindrone Acetate and Ethinyl Estradiol tablets USP, 1 mg/0.01 mg, Ethinyl Estradiol tablets USP, 0.01 mg and ...
Teva Women's Health to Present New Data at the 61st Annual Meeting of the American Congress of Obste
Bleeding Patterns with Three Ascending-Dose, Extended-Cycle Oral Contraceptives vs. Seasonale ® (Poster # 3, Poster Session #1: Contraception/Family Planning: Monday, May 6, 2013 from 10:30 a.m. to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback